U.S. SENATE TO EXAMINE DRUGS IN RACING

Medication and Performance Enhancing Drugs in Horseracing will be in the spotlight next Thursday in Washington, D.C., when the United States Senate's Committee on Commerce, Science and Transportation conducts a hearing that will bring together both opponents and proponents of the horse racing industry's current regulatory structure and permissive use of therapeutic medication in horses, including the race-day diuretic furosemide.

The hearing is scheduled for 2:30 p.m. in the Russell Building, Room 253. It will be lived-streamed at www.commerce.senate.gov.

Click Here to continue reading this article